WT
SCLN

Whittier Trust’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Whittier Trust’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,000
Closed -$11K – 1396
2017
Q3 		$11K Hold
1,000
– – ﹤0.01% 1019
2017
Q2 		$11K Hold
1,000
– – ﹤0.01% 984
2017
Q1 		$10K Hold
1,000
– – ﹤0.01% 1010
2016
Q4 		$11K Hold
1,000
– – ﹤0.01% 962
2016
Q3 		$10K Hold
1,000
– – ﹤0.01% 968
2016
Q2 		$13K Hold
1,000
– – ﹤0.01% 952
2016
Q1 		$11K Hold
1,000
– – ﹤0.01% 965
2015
Q4 		$9K Buy
+1,000
New +$8.37K ﹤0.01% 981

Whittier Trust's SCLN Position: Q4 2017 in Review

Whittier Trust sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2017, closing a stake of 1,000 shares — an estimated $11K sold.

Whittier Trust first reported a position in SCLN in Q4 2015 and held it in 8 quarters. The position peaked at $13K in Q2 2016. 0 funds tracked by Wall St. Rank hold SCLN as of Q4 2017.

  • Whittier Trust reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
  • Whittier Trust sold 1,000 Sciclone Pharmaceuticals Inc shares in Q4 2017, an estimated $11K.
  • Whittier Trust first reported a position in Sciclone Pharmaceuticals Inc in Q4 2015 and held it in 8 quarters.
  • Whittier Trust's Sciclone Pharmaceuticals Inc position peaked at $13K in Q2 2016.
  • 0 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2017.

Based on Whittier Trust's 13F filing for Q4 2017, filed 7 Feb 2018.